Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001680581-18-000002
Filing Date
2018-09-05
Accepted
2018-09-05 12:32:21
Documents
1
Effectiveness Date
2018-09-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10893
  Complete submission text file 0001680581-18-000002.txt   11915
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-320649 | Film No.: 181054483